The only topical retinoid without a generic alternative: tazarotene
Kircik, L.H.
Journal of Drugs in Dermatology Jdd 12(3): S52
2013
ISSN/ISBN: 1545-9616 PMID: 23545934 Document Number: 15495
Document emailed within 1 workday
Related Documents
Anderson, D.N.; Callender, V.D.; Del Rosso, J.Q.; Tanghetti, E.A.; Zane, L.T. 2004: Topical tazarotene in acne vulgaris: treatment approaches Cutis 74(4 Suppl): 16-21Deliduka, S.B.; Kwong, P.C. 2004: Treatment of Nevus comedonicus with topical tazarotene and calcipotriene Journal of Drugs in Dermatology: Jdd 3(6): 674-676
Del Rosso, J.Q.; Tanghetti, E. 2013: A status report on topical tazarotene in the management of acne vulgaris Journal of Drugs in Dermatology: Jdd 12(3): S53-S58
Shalita, A. 2004: Topical tazarotene: the BEST (balancing efficacy, speed, and tolerability) in acne trial Cutis 74(4 Suppl): 4-8
Leyden, J.; Grove, G.; Zerweck, C. 2004: Facial tolerability of topical retinoid therapy Journal of Drugs in Dermatology: Jdd 3(6): 641-651
Tramposch, K.M.; Nair, X.; Gendimenico, G.J.; Tetrault, G.B.; Chen, S.; Kiss, I.; Whiting, G.; Bonney, R.J. 1992: The pharmacology of a novel topical retinoid, BMY 30123: comparison with tretinoin Journal of Pharmacy and Pharmacology 44(5): 379-386
Weiss, J.S.; Shavin, J.S. 2004: Topical retinoid and antibiotic combination therapy for acne management Journal of Drugs in Dermatology: Jdd 3(2): 146-154
Ebling, A.M. 2001: Effectiveness of oral antibiotics and topical retinoid therapy in the treatment of acne in adolescents Pediatric Nursing 27(4): 410
Tanghetti, E.; Abramovits, W.; Solomon, B.; Loven, K.; Shalita, A. 2006: Tazarotene versus tazarotene plus clindamycin/benzoyl peroxide in the treatment of acne vulgaris: a multicenter, double-blind, randomized parallel-group trial Journal of Drugs in Dermatology: Jdd 5(3): 256-261
Fisher, A.A. 1988: Problems associated with "generic" topical medications Cutis 41(5): 313-314
Tanghetti, E.; Dhawan, S.; Green, L.; Ling, M.; Downie, J.; Germain, M.A.; Kasteler, J.S.; Kircik, L.; Oefelein, M.G.; Draelos, Z. 2011: Clinical evidence for the role of a topical anti-inflammatory agent in comedonal acne: findings from a randomized study of dapsone gel 5% in combination with tazarotene cream 0.1% in patients with acne vulgaris Journal of Drugs in Dermatology: Jdd 10(7): 783-792
Lewis, K.C.; Hochadel, J.F. 1999: Retinoid metabolism in the prostate: effects of administration of the synthetic retinoid N-(4-hydroxyphenyl)retinamide Cancer Research 59(23): 5947-5955
Van der Saag, P.T. 1996: Nuclear retinoid receptors: mediators of retinoid effects European Journal of Clinical Nutrition 50(Suppl 3): S24-S28
Del Rosso, J.Q.; Kircik, L.H. 2014: Transitioning from brand to generic with topical products and the importance of maintaining the formulation and therapeutic profiles of the original product: focus on clocortolone pivalate 0.1% cream Journal of Drugs in Dermatology: Jdd 13(7): S77-S83
Zaenglein, A.L.; Shamban, A.; Webster, G.; Del Rosso, J.; Dover, J.S.; Swinyer, L.; Stein, L.; Lin, X.; Draelos, Z.; Gold, M.; Thiboutot, D. 2013: A phase IV, open-label study evaluating the use of triple-combination therapy with minocycline HCl extended-release tablets, a topical antibiotic/retinoid preparation and benzoyl peroxide in patients with moderate to severe acne vulgaris Journal of Drugs in Dermatology: Jdd 12(6): 619-625
Seckin, D.; Cerman, A.Aksu.; Yildiz, A.; Ergun, T. 2009: Can topical calcipotriol be a treatment alternative in actinic keratoses? A preliminary report Journal of drugs in dermatology: JDD 8(5): 451-454
Beck, E.J.; Passarelli, C.; Lui, I.; Guichard, A.-C.; Simao, M.; De Lay, P.; Loures, L. 2014: Scaling-up the use of generic antiretrovirals in resource-limited countries: generic drugs for health Antiviral Therapy 19(Suppl 3): 117-123
Beck, E.J.; Passarelli, C.; Lui, I.; Guichard, A.-C.; Simao, M.; De Lay, P.; Loures, L. 2014: Scaling-up the use of generic antiretrovirals in resource-limited countries: generic drugs for health Antiviral Therapy 19(Suppl 3): 117-123
Boyd, J.; Sloan, S.; Meffert, J. 2004: Elephantiasis nostrum verrucosa of the abdomen: clinical results with tazarotene Journal of Drugs in Dermatology: Jdd 3(4): 446-448
Dosik, J.S.; Arsonnaud, S. 2007: Tolerability comparison of adapalene gel, 0.3% versus tazarotene cream, 0.05% in subjects with healthy skin Journal of Drugs in Dermatology: Jdd 6(6): 632-638